Rivastigmine as a Treatment for Methamphetamine Dependence

Completed · Phase 1 · Has a placebo group

Conditions studied: Methamphetamine Dependence, Substance Abuse, Methamphetamine Abuse

In brief

To study the effects of treatment with rivastigmine on craving produced by experimental administration of methamphetamine.

Key facts

Study ID

NCT01073319

Run by

Baylor College of Medicine

People needed

17

Starts

2009-07-01

Expected to finish

2010-07-01

Last updated by the study team

2012-07-27

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Michael E. DeBakey VA Medical Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.